293 related articles for article (PubMed ID: 27694262)
21. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
[TBL] [Abstract][Full Text] [Related]
22. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri).
Daniels AB; Liu GT; Volpe NJ; Galetta SL; Moster ML; Newman NJ; Biousse V; Lee AG; Wall M; Kardon R; Acierno MD; Corbett JJ; Maguire MG; Balcer LJ
Am J Ophthalmol; 2007 Apr; 143(4):635-41. PubMed ID: 17386271
[TBL] [Abstract][Full Text] [Related]
23. Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension.
Daou BJ; Sweid A; Weinberg JH; Starke RM; Sergott RC; Doermann AS; Hauge J; Zanaty M; Chalouhi N; Gooch R; Herial N; Zarzour H; Jabbour P; Rosenwasser RH; Tjoumakaris S
World Neurosurg; 2020 Oct; 142():e73-e80. PubMed ID: 32474095
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients.
Banik R; Kupersmith MJ; Wang JK; Garvin MK;
J Glaucoma; 2019 Apr; 28(4):352-356. PubMed ID: 30624392
[TBL] [Abstract][Full Text] [Related]
25. Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
Goyal A; Zarroli K
Medicine (Baltimore); 2023 Oct; 102(42):e35545. PubMed ID: 37861536
[TBL] [Abstract][Full Text] [Related]
26. The idiopathic intracranial hypertension treatment trial: design considerations and methods.
Friedman DI; McDermott MP; Kieburtz K; Kupersmith M; Stoutenburg A; Keltner JL; Feldon SE; Schron E; Corbett JJ; Wall M;
J Neuroophthalmol; 2014 Jun; 34(2):107-17. PubMed ID: 24739993
[TBL] [Abstract][Full Text] [Related]
27. An update of idiopathic intracranial hypertension.
Madriz Peralta G; Cestari DM
Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
[TBL] [Abstract][Full Text] [Related]
28. Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Wang JK; Kardon RH; Ledolter J; Sibony PA; Kupersmith MJ; Garvin MK;
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2554-2565. PubMed ID: 28492874
[TBL] [Abstract][Full Text] [Related]
29. Sleep apnea and intracranial hypertension in men.
Lee AG; Golnik K; Kardon R; Wall M; Eggenberger E; Yedavally S
Ophthalmology; 2002 Mar; 109(3):482-5. PubMed ID: 11874748
[TBL] [Abstract][Full Text] [Related]
30. Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.
Espino Barros Palau A; Morgan ML; Yalamanchili S; Lee AG
Can J Ophthalmol; 2016 Aug; 51(4):e121-e125. PubMed ID: 27521679
[No Abstract] [Full Text] [Related]
31. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.
Wall M; Kupersmith MJ; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; McDermott MP;
JAMA Neurol; 2014 Jun; 71(6):693-701. PubMed ID: 24756302
[TBL] [Abstract][Full Text] [Related]
32. Intracranial idiopathic hypertension: 1-year follow-up study.
D'Amico D; Curone M; Erbetta A; Farago' G; Bianchi-Marzoli S; Ciasca P; Bussone G; Chiapparini L
Neurol Sci; 2014 May; 35 Suppl 1():177-9. PubMed ID: 24867861
[TBL] [Abstract][Full Text] [Related]
33. The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.
Beck RW
J Neuroophthalmol; 2016 Mar; 36(1):1-3. PubMed ID: 26882233
[No Abstract] [Full Text] [Related]
34. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
Lee IJ; Maccheron LJ; Kwan AS
J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
[TBL] [Abstract][Full Text] [Related]
35. CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
Kattah JC; Pula JH; Mejico LJ; McDermott MP; Kupersmith MJ; Wall M
J Neurol; 2015 Oct; 262(10):2271-4. PubMed ID: 26159101
[TBL] [Abstract][Full Text] [Related]
36. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
[TBL] [Abstract][Full Text] [Related]
37. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.
Miskala PH; Hawkins BS; Mangione CM; Bass EB; Bressler NM; Dong LM; Marsh MJ; McCaffrey LD;
Arch Ophthalmol; 2003 Apr; 121(4):531-9. PubMed ID: 12695250
[TBL] [Abstract][Full Text] [Related]
38. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25.
Raphael BA; Galetta KM; Jacobs DA; Markowitz CE; Liu GT; Nano-Schiavi ML; Galetta SL; Maguire MG; Mangione CM; Globe DR; Balcer LJ
Am J Ophthalmol; 2006 Dec; 142(6):1026-35. PubMed ID: 17046704
[TBL] [Abstract][Full Text] [Related]
39. [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
Noda M; Sonoda Y; Takemoto M; Kira R
No To Hattatsu; 2017 May; 49(3):207-10. PubMed ID: 30113799
[TBL] [Abstract][Full Text] [Related]
40. Metamorphopsia as an initial complaint of idiopathic intracranial hypertension.
Warner JE; Katz BJ
Arch Ophthalmol; 2005 Jul; 123(7):1003-6. PubMed ID: 16009846
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
